medigraphic.com
Órgano Oficial del Hospital Angeles Health System

2016, Número 3

Siguiente >>

Acta Med 2016; 14 (3)


Tratamiento quirúrgico local del cáncer bien diferenciado de tiroides. Controversia resuelta

Gallegos HJF

Idioma: Español
Referencias bibliográficas: 10
Paginas: 129-130
Archivo PDF: 83.31 Kb.


FRAGMENTO

Se denomina cáncer bien diferenciado de tiroides (CABDT) a un espectro de neoplasias malignas que afectan esta glándula: el carcinoma papilar, el folicular y el mixto (papilar-folicular); el más frecuente de ellos es el papilar; las tres variantes histológicas, aunque con comportamiento biológico diferente, pueden ser tratadas de forma similar, siempre con base en la etapa y los factores de pronóstico.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009; 19 (11): 1167-1214.

  2. Bilimoria KY, Bentrem DJ, Ko CY, Stewart AK, Winchester DP, Talamonti MS et al. Extent of surgery affects survival for papillary thyroid cancer. Ann Surg. 2007; 246 (3): 375-381; discussion 381-384.

  3. Grant CS, Hay ID, Gough IR, Bergstralh EJ, Goellner JR, McConahey WM. Local recurrence in papillary thyroid carcinoma: is extent of surgical resection important? Surgery. 1988; 104 (6): 954-962.

  4. Hay ID, Grant CS, Bergstralh EJ, Thompson GB, van Heerden JA, Goellner JR. Unilateral total lobectomy: is it sufficient surgical treatment for patients with AMES low-risk papillary thyroid carcinoma? Surgery. 1998; 124 (6): 958-964; discussion 964-966.

  5. Mazzaferri EL, Kloos RT. Clinical review 128: Current approaches to primary therapy for papillary and follicular thyroid cancer. J Clin Endocrinol Metab. 2001; 86 (4): 1447-163.

  6. Adam MA, Pura J, Gu L, Dinan MA, Tyler DS, Reed SD et al. Extent of surgery for papillary thyroid cancer is not associated with survival: an analysis of 61,775 patients. Ann Surg. 2014; 260 (4): 601-605; discussion 605-607.

  7. Haigh PI, Urbach DR, Rotstein LE. Extent of thyroidectomy is not a major determinant of survival in low- or high-risk papillary thyroid cancer. Ann Surg Oncol. 2005; 12 (1): 81-89.

  8. Barney BM, Hitchcock YJ, Sharma P, Shrieve DC, Tward JD. Overall and cause-specific survival for patients undergoing lobectomy, near-total, or total thyroidectomy for differentiated thyroid cancer. Head Neck. 2011; 33 (5): 645-649.

  9. Mendelsohn AH, Elashoff DA, Abemayor E, St John MA. Surgery for papillary thyroid carcinoma: is lobectomy enough? Arch Otolaryngol Head Neck Surg. 2010; 136 (11): 1055-1061.

  10. Nixon IJ, Ganly I, Patel SG, Palmer FL, Whitcher MM, Tuttle RM et al. Thyroid lobectomy for treatment of well differentiated intrathyroid malignancy. Surgery. 2012; 151 (4): 571-579.




2020     |     www.medigraphic.com